Skip to Content

Xylem Earnings: Measurement and Control Solutions Maintains Strong Momentum

""

We’ve raised our fair value estimate for narrow-moat-rated Xylem XYL to $104 from $97 after the water technology firm posted solid second-quarter results and raised its full-year outlook for the second time this year. The fair value adjustment reflects the acquisition of Evoqua, our more optimistic near-term revenue growth projections, and time value of money.

Xylem grew its second-quarter organic revenue by 15% year over year, with double-digit growth across all segments and end markets. Compared with the prior-year period, organic revenue was up by 12% in applied water, 13% in water infrastructure, and 21% in measurement and control solutions. The measurement and control solutions segment continued to benefit from chip supply improvement, and volume leverage helped it deliver a 590-basis-point year-over-year adjusted EBITDA margin expansion, from 9.8% to 15.7%. The new integrated solutions and services segment grew its pro forma revenue by 12% year over year. Xylem expanded its second-quarter adjusted EBITDA margin by 250 basis points, from 16.6% to 19.1%, thanks to volume leverage, productivity, and a positive price-cost spread.

Xylem raised its guidance range for full-year 2023 and now anticipates adjusted EPS of $3.50-$3.70, up from $3.00-$3.25 previously. At the midpoint the revised outlook reflects a roughly $0.28 organic guidance increase and a $0.20 boost from the Evoqua acquisition. Management said on the call that it expects cost synergies from the acquisition to reach a run rate of around $40 million by the end of the year and $140 million within three years. We are encouraged by the continued strong momentum in measurement and control solutions. We think that the segment’s $2.4 billion backlog positions it well for continued growth and strong incremental margins in the second half of the year.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Krzysztof Smalec

Equity Analyst
More from Author

Krzysztof Smalec, CFA, is an equity analyst on the industrials team for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers diversified industrial companies, including producers of industrial gases.

Before joining Morningstar in 2018, Smalec spent six years working as a valuation consultant at Marshall & Stevens, where he specialized in valuing structured investments in renewable energy projects.

Smalec holds a bachelor’s degree in finance and economics from DePaul University. He also holds the Chartered Financial Analyst® designation.

Sponsor Center